Day One Biopharmaceuticals

Showing 3442 articles
Business

Ondas Secures Coveted Pentagon 'Blue List' Approval for Optimus Drone, Fueling Investor Debate on Valuation

Ondas Holdings' flagship Optimus drone system has received the Defense Contract Management Agency's critical 'Blue List' certification, clearing it for broader U.S. defense and national security deployment. The milestone has ignited a surge in the company's stock while prompting analysts to scrutinize its long-term path to converting regulatory approval into sustainable revenue.

Business

NewtekOne Posts Record 2025, Touts Bank Charter Success and Disruptive Tech Edge

NewtekOne (NASDAQ: NEWT) reported robust Q4 and full-year 2025 results, highlighting the third anniversary of its OCC-chartered bank. The financial holding company saw net income rise 16.4% to $80 million, driven by strong deposit growth, successful securitizations, and a focus on serving independent business owners with long-term, 'patient capital' loans.